You are here

Error message

The MailChimp PHP library is missing the required GuzzleHttp library. Please check the installation notes in README.txt.

Warning message

The subscription service is currently unavailable. Please try again later.

Perspective on the DDMoRe project published in CPT:PSP

Drug and Disease Model Resources: A Consortium to Create Standards and Tools to Enhance Model-Based Drug development. L. Harnisch, I. Matthews, J. Chard and M.O. Karlsson on behalf of the DDMoRe consortium Partners and Contributors.  CPT: Pharmacometrics & Systems Pharmacology, 2013, 2, e34

Abstract

Model-based drug development (MBDD) is accepted as a vital approach in understanding patients’ drug-related benefit and risk by integrating quantitative information integration from diverse sources collected throughout drug development. This perspective introduces the activities of the Drug and Disease Model Resources (DDMoRe) consortium, founded in 2011 through the Innovative Medicines Initiative Joint Undertaking (IMI-JU) as a European public–private partnership to address a lack of common tools, languages, and standards for modeling and simulation (M&S) to improve model-based knowledge integration

Associated members

SMEs
Jonathan Chard's picture
Jonathan Chard
Mango Business Solutions
EFPIA
Lutz Harnisch's picture
Lutz Harnisch
Pfizer
Academia
Mats Karlsson's picture
Mats Karlsson
Uppsala Universitet